Osaka University School of Medicine has agreed with Sumitomo Mitsui Banking Corporation (Chiyoda-ku, Tokyo, Takeshi Kunibe) to conclude a partnership agreement to realize innovation in the fields of health and medical care.For the purpose of promoting industry-academia collaboration that makes use of research results in business, we will receive support for promotion and commercialization of academic research.
According to Sumitomo Mitsui Banking Corporation, the contents of the collaboration include promotion of academic research through customer introduction, support for commercialization of research results, and promotion of social utilization.At the same time, we will promote the development and exchange of human resources that transcend organizations and fields.
The Kansai region has been designated as a National Strategic Special Zone in the fields of health and medical care, and efforts to create innovation are expected.Among them, Osaka University is engaged in advanced activities in the fields of regenerative medicine, medical device development, and sports science, and the affiliated hospital is positioned as the only core hospital for clinical research in the National Strategic Special Zone in Japan, and is actively innovating. We are advancing efforts toward.For this reason, Osaka University School of Medicine has set up an industry-academia collaboration and cross-innovation organization in the fields of health and medical care.In addition to Sumitomo Mitsui Banking Corporation, we have signed cooperation agreements with major pharmaceutical companies such as Rohto Pharmaceutical (Ikuno-ku, Osaka, President Toshiaki Yoshino).
